Urinary Tract Infection Treatment Market 2027 By Drug Class, Indication, Distribution Channel | The Insight Partners

Urinary Tract Infection Treatment Market to 2027 - Global Analysis and Forecasts by Drug Class (Penicillin and Combinations, Quinolones, Cephalosporin, Aminoglycoside Antibiotics, Sulphonamides); Indication (Complicated Urinary Tract Infection, Uncomplicated Urinary Tract Infection,); Distribution Channel (Hospital Pharmacies, Gynaecology and Urology Clinics, Drug Stores, Retail Pharmacies, Online Drug Stores)

Report Code: TIPRE00005931 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION

Urinary Tract Infection refers to the infection that occurs in different parts of the urinary system, especially the lower part. The female are more affected to the disease compared to the males as their urethra is comparatively smaller and closer to the anus than the men.

MARKET DYNAMICS

The Urinary Tract Infection Treatment market is anticipated to grow in the forecast, owing to the factors such as growth in the prevalence of uti among women, increasing number of hospital visits for the diseases, high demand for the antibiotics, growing number of generic players, and growing awareness. Nevertheless, developments off the antibacterial resistance is expected to hamper the growth of the market during the forecast period.

MARKET SCOPE

The "Global Urinary Tract Infection Treatment Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Urinary Tract Infection Treatment market with detailed market segmentation by drug class, indication, distribution channel and geography. The global Urinary Tract Infection Treatment market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Urinary Tract Infection Treatment market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global Urinary Tract Infection Treatment market is segmented on the basis of drug class, indication and distribution channel. Based on drug class the market is segmented into Penicillin and Combinations, Quinolones, Cephalosporin, Aminoglycoside Antibiotics, Sulphonamides. Based on indication the market is segmented into Complicated Urinary Tract Infection, Uncomplicated Urinary Tract Infection. Based on distribution channel the market is segmented into Hospital Pharmacies, Gynaecology and Urology Clinics, Drug Stores, Retail Pharmacies, Online Drug Stores.


REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Urinary Tract Infection Treatment market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Urinary Tract Infection Treatment market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Urinary Tract Infection Treatment market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Urinary Tract Infection Treatment market in these regions.


MARKET PLAYERS

The reports cover key developments in the Urinary Tract Infection Treatment market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Urinary Tract Infection Treatment market are anticipated to lucrative growth opportunities in the future with the rising demand for Urinary Tract Infection Treatment market in the global market. Below mentioned is the list of few companies engaged in the Urinary Tract Infection Treatment market.

The report also includes the profiles of Urinary Tract Infection Treatment market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

- Mayo Foundation for Medical Education and Research (MFMER)
- Lupin Pharmaceuticals, Inc.
- Fortis Healthcare
- Teva Pharmaceutical Industries Ltd
- Sun Pharmaceutical Industries Ltd
- Mylan N.V.
- AstraZeneca
- Novartis Pharmaceuticals Corporation
- ALLERGAN
- Pfizer Inc

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Urinary Tract Infection Treatment Market - By Drug Class
1.3.2 Urinary Tract Infection Treatment Market - By Indication
1.3.3 Urinary Tract Infection Treatment Market - By Distribution Channel
1.3.4 Urinary Tract Infection Treatment Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. URINARY TRACT INFECTION TREATMENT MARKET L and SCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. URINARY TRACT INFECTION TREATMENT MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS and RESTRAINTS
6. URINARY TRACT INFECTION TREATMENT MARKET - GLOBAL MARKET ANALYSIS
6.1. URINARY TRACT INFECTION TREATMENT - GLOBAL MARKET OVERVIEW
6.2. URINARY TRACT INFECTION TREATMENT - GLOBAL MARKET and FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. URINARY TRACT INFECTION TREATMENT MARKET - REVENUE and FORECASTS TO 2027 - DRUG CLASS
7.1. OVERVIEW
7.2. DRUG CLASS MARKET FORECASTS and ANALYSIS
7.3. PENICILLIN and COMBINATIONS
7.3.1. Overview
7.3.2. Penicillin and Combinations Market Forecast and Analysis
7.3.3. Amoxicillin Market
7.3.3.1. Overview
7.3.3.2. Amoxicillin Market Forecast and Analysis
7.3.4. Amoxicillin and Clavulanate Potassium Market
7.3.4.1. Overview
7.3.4.2. Amoxicillin and Clavulanate Potassium Market Forecast and Analysis
7.3.5. Others Market
7.3.5.1. Overview
7.3.5.2. Others Market Forecast and Analysis
7.4. QUINOLONES
7.4.1. Overview
7.4.2. Quinolones Market Forecast and Analysis
7.4.3. Ciprofloxaxin Market
7.4.3.1. Overview
7.4.3.2. Ciprofloxaxin Market Forecast and Analysis
7.4.4. Levofloxaxin Market
7.4.4.1. Overview
7.4.4.2. Levofloxaxin Market Forecast and Analysis
7.4.5. Nalidixic acid Market
7.4.5.1. Overview
7.4.5.2. Nalidixic acid Market Forecast and Analysis
7.4.6. Norfloxacin Market
7.4.6.1. Overview
7.4.6.2. Norfloxacin Market Forecast and Analysis
7.4.7. Others Market
7.4.7.1. Overview
7.4.7.2. Others Market Forecast and Analysis
7.5. CEPHALOSPORIN
7.5.1. Overview
7.5.2. Cephalosporin Market Forecast and Analysis
7.5.3. Ceftriaxone Market
7.5.3.1. Overview
7.5.3.2. Ceftriaxone Market Forecast and Analysis
7.5.4. Cefuroxime Market
7.5.4.1. Overview
7.5.4.2. Cefuroxime Market Forecast and Analysis
7.5.5. Cefixime Market
7.5.5.1. Overview
7.5.5.2. Cefixime Market Forecast and Analysis
7.5.6. Cephalexin Market
7.5.6.1. Overview
7.5.6.2. Cephalexin Market Forecast and Analysis
7.6. AMINOGLYCOSIDE ANTIBIOTICS
7.6.1. Overview
7.6.2. Aminoglycoside Antibiotics Market Forecast and Analysis
7.7. SULPHONAMIDES
7.7.1. Overview
7.7.2. Sulphonamides Market Forecast and Analysis
8. URINARY TRACT INFECTION TREATMENT MARKET - REVENUE and FORECASTS TO 2027 - INDICATION
8.1. OVERVIEW
8.2. INDICATION MARKET FORECASTS and ANALYSIS
8.3. COMPLICATED URINARY TRACT INFECTION
8.3.1. Overview
8.3.2. Complicated Urinary Tract Infection Market Forecast and Analysis
8.4. UNCOMPLICATED URINARY TRACT INFECTION
8.4.1. Overview
8.4.2. Uncomplicated Urinary Tract Infection Market Forecast and Analysis
8.5.
8.5.1. Overview
8.5.2. Market Forecast and Analysis
9. URINARY TRACT INFECTION TREATMENT MARKET - REVENUE and FORECASTS TO 2027 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS and ANALYSIS
9.3. HOSPITAL PHARMACIES
9.3.1. Overview
9.3.2. Hospital Pharmacies Market Forecast and Analysis
9.4. GYNAECOLOGY and UROLOGY CLINICS
9.4.1. Overview
9.4.2. Gynaecology and Urology Clinics Market Forecast and Analysis
9.5. DRUG STORES
9.5.1. Overview
9.5.2. Drug Stores Market Forecast and Analysis
9.6. RETAIL PHARMACIES
9.6.1. Overview
9.6.2. Retail Pharmacies Market Forecast and Analysis
9.7. ONLINE DRUG STORES
9.7.1. Overview
9.7.2. Online Drug Stores Market Forecast and Analysis
10. URINARY TRACT INFECTION TREATMENT MARKET REVENUE and FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Urinary Tract Infection Treatment Market Overview
10.1.2 North America Urinary Tract Infection Treatment Market Forecasts and Analysis
10.1.3 North America Urinary Tract Infection Treatment Market Forecasts and Analysis - By Drug Class
10.1.4 North America Urinary Tract Infection Treatment Market Forecasts and Analysis - By Indication
10.1.5 North America Urinary Tract Infection Treatment Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Urinary Tract Infection Treatment Market Forecasts and Analysis - By Countries
10.1.6.1 United States Urinary Tract Infection Treatment Market
10.1.6.1.1 United States Urinary Tract Infection Treatment Market by Drug Class
10.1.6.1.2 United States Urinary Tract Infection Treatment Market by Indication
10.1.6.1.3 United States Urinary Tract Infection Treatment Market by Distribution Channel
10.1.6.2 Canada Urinary Tract Infection Treatment Market
10.1.6.2.1 Canada Urinary Tract Infection Treatment Market by Drug Class
10.1.6.2.2 Canada Urinary Tract Infection Treatment Market by Indication
10.1.6.2.3 Canada Urinary Tract Infection Treatment Market by Distribution Channel
10.1.6.3 Mexico Urinary Tract Infection Treatment Market
10.1.6.3.1 Mexico Urinary Tract Infection Treatment Market by Drug Class
10.1.6.3.2 Mexico Urinary Tract Infection Treatment Market by Indication
10.1.6.3.3 Mexico Urinary Tract Infection Treatment Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Urinary Tract Infection Treatment Market Overview
10.2.2 Europe Urinary Tract Infection Treatment Market Forecasts and Analysis
10.2.3 Europe Urinary Tract Infection Treatment Market Forecasts and Analysis - By Drug Class
10.2.4 Europe Urinary Tract Infection Treatment Market Forecasts and Analysis - By Indication
10.2.5 Europe Urinary Tract Infection Treatment Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Urinary Tract Infection Treatment Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Urinary Tract Infection Treatment Market
10.2.6.1.1 Germany Urinary Tract Infection Treatment Market by Drug Class
10.2.6.1.2 Germany Urinary Tract Infection Treatment Market by Indication
10.2.6.1.3 Germany Urinary Tract Infection Treatment Market by Distribution Channel
10.2.6.2 France Urinary Tract Infection Treatment Market
10.2.6.2.1 France Urinary Tract Infection Treatment Market by Drug Class
10.2.6.2.2 France Urinary Tract Infection Treatment Market by Indication
10.2.6.2.3 France Urinary Tract Infection Treatment Market by Distribution Channel
10.2.6.3 Italy Urinary Tract Infection Treatment Market
10.2.6.3.1 Italy Urinary Tract Infection Treatment Market by Drug Class
10.2.6.3.2 Italy Urinary Tract Infection Treatment Market by Indication
10.2.6.3.3 Italy Urinary Tract Infection Treatment Market by Distribution Channel
10.2.6.4 Spain Urinary Tract Infection Treatment Market
10.2.6.4.1 Spain Urinary Tract Infection Treatment Market by Drug Class
10.2.6.4.2 Spain Urinary Tract Infection Treatment Market by Indication
10.2.6.4.3 Spain Urinary Tract Infection Treatment Market by Distribution Channel
10.2.6.5 United Kingdom Urinary Tract Infection Treatment Market
10.2.6.5.1 United Kingdom Urinary Tract Infection Treatment Market by Drug Class
10.2.6.5.2 United Kingdom Urinary Tract Infection Treatment Market by Indication
10.2.6.5.3 United Kingdom Urinary Tract Infection Treatment Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Urinary Tract Infection Treatment Market Overview
10.3.2 Asia-Pacific Urinary Tract Infection Treatment Market Forecasts and Analysis
10.3.3 Asia-Pacific Urinary Tract Infection Treatment Market Forecasts and Analysis - By Drug Class
10.3.4 Asia-Pacific Urinary Tract Infection Treatment Market Forecasts and Analysis - By Indication
10.3.5 Asia-Pacific Urinary Tract Infection Treatment Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Urinary Tract Infection Treatment Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Urinary Tract Infection Treatment Market
10.3.6.1.1 Australia Urinary Tract Infection Treatment Market by Drug Class
10.3.6.1.2 Australia Urinary Tract Infection Treatment Market by Indication
10.3.6.1.3 Australia Urinary Tract Infection Treatment Market by Distribution Channel
10.3.6.2 China Urinary Tract Infection Treatment Market
10.3.6.2.1 China Urinary Tract Infection Treatment Market by Drug Class
10.3.6.2.2 China Urinary Tract Infection Treatment Market by Indication
10.3.6.2.3 China Urinary Tract Infection Treatment Market by Distribution Channel
10.3.6.3 India Urinary Tract Infection Treatment Market
10.3.6.3.1 India Urinary Tract Infection Treatment Market by Drug Class
10.3.6.3.2 India Urinary Tract Infection Treatment Market by Indication
10.3.6.3.3 India Urinary Tract Infection Treatment Market by Distribution Channel
10.3.6.4 Japan Urinary Tract Infection Treatment Market
10.3.6.4.1 Japan Urinary Tract Infection Treatment Market by Drug Class
10.3.6.4.2 Japan Urinary Tract Infection Treatment Market by Indication
10.3.6.4.3 Japan Urinary Tract Infection Treatment Market by Distribution Channel
10.3.6.5 South Korea Urinary Tract Infection Treatment Market
10.3.6.5.1 South Korea Urinary Tract Infection Treatment Market by Drug Class
10.3.6.5.2 South Korea Urinary Tract Infection Treatment Market by Indication
10.3.6.5.3 South Korea Urinary Tract Infection Treatment Market by Distribution Channel
10.4. MIDDLE EAST and AFRICA
10.4.1 Middle East and Africa Urinary Tract Infection Treatment Market Overview
10.4.2 Middle East and Africa Urinary Tract Infection Treatment Market Forecasts and Analysis
10.4.3 Middle East and Africa Urinary Tract Infection Treatment Market Forecasts and Analysis - By Drug Class
10.4.4 Middle East and Africa Urinary Tract Infection Treatment Market Forecasts and Analysis - By Indication
10.4.5 Middle East and Africa Urinary Tract Infection Treatment Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Urinary Tract Infection Treatment Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Urinary Tract Infection Treatment Market
10.4.6.1.1 South Africa Urinary Tract Infection Treatment Market by Drug Class
10.4.6.1.2 South Africa Urinary Tract Infection Treatment Market by Indication
10.4.6.1.3 South Africa Urinary Tract Infection Treatment Market by Distribution Channel
10.4.6.2 Saudi Arabia Urinary Tract Infection Treatment Market
10.4.6.2.1 Saudi Arabia Urinary Tract Infection Treatment Market by Drug Class
10.4.6.2.2 Saudi Arabia Urinary Tract Infection Treatment Market by Indication
10.4.6.2.3 Saudi Arabia Urinary Tract Infection Treatment Market by Distribution Channel
10.4.6.3 U.A.E Urinary Tract Infection Treatment Market
10.4.6.3.1 U.A.E Urinary Tract Infection Treatment Market by Drug Class
10.4.6.3.2 U.A.E Urinary Tract Infection Treatment Market by Indication
10.4.6.3.3 U.A.E Urinary Tract Infection Treatment Market by Distribution Channel
10.5. SOUTH and CENTRAL AMERICA
10.5.1 South and Central America Urinary Tract Infection Treatment Market Overview
10.5.2 South and Central America Urinary Tract Infection Treatment Market Forecasts and Analysis
10.5.3 South and Central America Urinary Tract Infection Treatment Market Forecasts and Analysis - By Drug Class
10.5.4 South and Central America Urinary Tract Infection Treatment Market Forecasts and Analysis - By Indication
10.5.5 South and Central America Urinary Tract Infection Treatment Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Urinary Tract Infection Treatment Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Urinary Tract Infection Treatment Market
10.5.6.1.1 Brazil Urinary Tract Infection Treatment Market by Drug Class
10.5.6.1.2 Brazil Urinary Tract Infection Treatment Market by Indication
10.5.6.1.3 Brazil Urinary Tract Infection Treatment Market by Distribution Channel
10.5.6.2 Argentina Urinary Tract Infection Treatment Market
10.5.6.2.1 Argentina Urinary Tract Infection Treatment Market by Drug Class
10.5.6.2.2 Argentina Urinary Tract Infection Treatment Market by Indication
10.5.6.2.3 Argentina Urinary Tract Infection Treatment Market by Distribution Channel
11. INDUSTRY L and SCAPE
11.1. MERGERS and ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS and JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS and OTHER STRATEGIC DEVELOPMENTS
12. URINARY TRACT INFECTION TREATMENT MARKET, KEY COMPANY PROFILES
12.1. MAYO FOUNDATION FOR MEDICAL EDUCATION and RESEARCH (MFMER)
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. LUPIN PHARMACEUTICALS, INC
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. FORTIS HEALTHCARE
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. TEVA PHARMACEUTICAL INDUSTRIES LTD
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. SUN PHARMACEUTICAL INDUSTRIES LTD
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. MYLAN N.V
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. ASTRAZENECA
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. NOVARTIS PHARMACEUTICALS CORPORATION
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. ALLERGAN
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. PFIZER INC
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

- Mayo Foundation for Medical Education and Research (MFMER)
- Lupin Pharmaceuticals, Inc.
- Fortis Healthcare
- Teva Pharmaceutical Industries Ltd
- Sun Pharmaceutical Industries Ltd
- Mylan N. V.
- AstraZeneca
- Novartis Pharmaceuticals Corporation
- ALLERGAN
- Pfizer Inc